GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Imugene Ltd (OTCPK:IUGNF) » Definitions » Other Current Liabilities

IUGNF (Imugene) Other Current Liabilities : $5.98 Mil (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Imugene Other Current Liabilities?

Imugene's other current liabilities for the quarter that ended in Dec. 2024 was $5.98 Mil.

Imugene's quarterly other current liabilities declined from Dec. 2023 ($16.40 Mil) to Jun. 2024 ($13.66 Mil) and declined from Jun. 2024 ($13.66 Mil) to Dec. 2024 ($5.98 Mil).

Imugene's annual other current liabilities increased from Jun. 2022 ($1.31 Mil) to Jun. 2023 ($1.61 Mil) and increased from Jun. 2023 ($1.61 Mil) to Jun. 2024 ($13.66 Mil).

Imugene Other Current Liabilities Historical Data

The historical data trend for Imugene's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imugene Other Current Liabilities Chart

Imugene Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.11 2.36 1.31 1.61 13.66

Imugene Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.46 1.61 16.40 13.66 5.98

Imugene Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Imugene Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Imugene's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Imugene Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Imugene Ltd (OTCPK:IUGNF) » Definitions » Other Current Liabilities
Comparable Companies
ASX:RAC ASX:DXB ASX:ALA ASX:PAR ASX:ACW ASX:AGN ASX:OCC ASX:RCE ASX:EZZ ASX:ATH VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
ILA:Germany IMU:Australia
Address
4-6 Bligh Street, Suite 12.01, Level 12, Sydney, NSW, AUS, 2000
Website
https://www.imugene.com
Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its products include HER-Vaxx, PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment is the Research and Development of oncolytic immunotherapies.